Company Filing History:
Years Active: 2020-2025
Title: Hao-Wei Shih: Innovator in Pharmaceutical Chemistry
Introduction
Hao-Wei Shih is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 7 patents to his name, Shih's work has the potential to impact the treatment of various neurological and psychological conditions.
Latest Patents
Among his latest patents, Shih has developed ketamine derivatives and compositions thereof. These ketamine derivatives, when administered orally, provide increased bioavailability of ketamine in the systemic circulation. This innovation holds promise for treating neurological diseases, psychological disorders, and pain management. Additionally, he has disclosed methods for synthesizing 4-valyloxybutyric acid, employing diverse protecting group strategies and reaction conditions. These synthetic methods are crucial for preparing compounds that serve as intermediates in the production of 4-valyloxybutyric acid.
Career Highlights
Hao-Wei Shih has worked with notable companies such as Xwpharma Ltd. and Xw Laboratories Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development. His innovative approaches have garnered attention in the scientific community, contributing to advancements in drug formulation and synthesis.
Collaborations
Shih has collaborated with esteemed colleagues, including Jia-Ning Xiang and Wai-Si Eng. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment for research and innovation.
Conclusion
Hao-Wei Shih's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments and drug development.